Cite
MLA Citation
Eugenio Fernandez et al.. “P-190 Personalized Immunotherapy with Cell-Encapsulation Technology for 2nd line R/M HNSCC: Safety and Early Efficacy Data from all HNSCC patients treated with MVX-ONCO-1 in two clinical trials.” Oral oncology, vol. 118, n.d., pp. 6–. http://access.bl.uk/ark:/81055/vdc_100133913362.0x000034